Muscle Spasticity Clinical Trial
Official title:
Optimization of Physical Focal Stimulation Parameters for Improving Spasticity and Identification of Neurophysiological Mechanism
Verified date | October 2014 |
Source | Seoul National University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Korea: Institutional Review Board |
Study type | Interventional |
The overall aim of the proposed study is to determine optimal parameter of focal muscle
vibration for improving spasticity and identify neurophysiological mechanism in healthy
subjects.
In investigation I-1, subjects will undergo focal muscle vibration with 40, 80, 120 Hz
frequency at the medial gastrocnemius muscles (mGCM). As a surrogate maker of spasticity,
H-reflex and compound motor action potential (CMAP) of the tibial nerve at mGCM will be
recorded pre, during, and post vibration.
In investigation I-2, subjects will undergo focal muscle vibration with 0.1, 0.3, 0.5 mm
amplitude at mGCM. H-reflex and CMAP of the tibial nerve at mGCM will be recorded pre,
during, and post vibration.
In investigation II, subjects will undergo focal muscle vibration with predetermined
parameters by the investigation I at mGCM. H-reflex and CMAP of the tibial nerve and motor
evoked potential at mGCM will be recorded pre, during, and post vibration.
Status | Completed |
Enrollment | 17 |
Est. completion date | September 2014 |
Est. primary completion date | March 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Healthy volunteer Exclusion Criteria: - Unstable medical conditions - History of epilepsy - History of drug abuse |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Seoul National University Hospital | Seoul |
Lead Sponsor | Collaborator |
---|---|
Seoul National University Hospital | Korea Institute of Science and Technology |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | H/M ratio | The ratio of maximal H-reflex amplitude (mV) to CMAP amplitude (mV) recorded at mGCM | baseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibration | No |
Secondary | H amplitude | maximal H-reflex amplitude (mV) recorded at mGCM | baseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibration | No |
Secondary | M amplitude | CMAP amplitude (mV) recorded at mGCM | baseline, 1, 5 and 10 minutes during vibration, and 1 and 5 minutes after vibration | No |
Secondary | motor evoked potential (MEP) amplitude | Transcranial magnetic stimulation on the contralateral leg motor cortex is used to measure MEP at mGCM. | baseline, 10 minutes during vibration, and 5 minutes after vibration | No |
Secondary | Resting motor threshold (RMT) | Resting motor threshold (%) is defined as the minimal intensity of TMS capable of inducing MEPs greater than 100µV peak-to-peak amplitude in at least 3 of 5 trials. | baseline, 10 minutes during vibration, and 5 minutes after vibration | No |
Secondary | Short interval intracortical inhibition | Short interval intracortical inhibition is recorded by using conditioning stimulus of 90% RMT and test stimulus of 120% RMT with 1ms interval. | baseline, 10 minutes during vibration, and 5 minutes after vibration | No |
Secondary | Intracortical facilitation | Intracortical facilitation is recorded by using conditioning stimulus of 90% RMT and test stimulus of 120% RMT with 10ms interval. | baseline, 10 minutes during vibration, and 5 minutes after vibration | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04535479 -
Dry Needling for Spasticity in Stroke
|
N/A | |
Completed |
NCT02907775 -
Multi-channel Stimulation for Post Stroke Spasticity (MUSTS)
|
N/A | |
Recruiting |
NCT04530955 -
Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)
|
N/A | |
Active, not recruiting |
NCT03521076 -
Randomized Controlled Trial of Virtual Reality
|
N/A | |
Completed |
NCT03080454 -
The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke
|
Phase 1/Phase 2 | |
Completed |
NCT02546999 -
Does Botulinum Toxin A Make Walking Easier in Children With Cerebral Palsy?
|
Phase 4 | |
Active, not recruiting |
NCT01041157 -
Botulinum Toxin Injection Efficiency
|
Phase 1 | |
Terminated |
NCT00532532 -
Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT00535938 -
MDs on Botox Utility (MOBILITY)
|
N/A | |
Terminated |
NCT00531466 -
Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
|
Phase 2 | |
Completed |
NCT05546190 -
A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)
|
||
Recruiting |
NCT06117020 -
Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals
|
Phase 1 | |
Completed |
NCT01603628 -
BOTOX® Treatment in Pediatric Lower Limb Spasticity
|
Phase 3 | |
Completed |
NCT05510726 -
Quantitative Evaluation of Muscle Stiffness in Neurological Patients With Muscle Overactivity
|
||
Not yet recruiting |
NCT04378946 -
Error Augmentation Motor Learning Training Approach in Stroke Patients
|
N/A | |
Completed |
NCT01603615 -
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
|
Phase 3 | |
Completed |
NCT01251380 -
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
|
Phase 3 | |
Completed |
NCT00549783 -
BOTOX® Economic Spasticity Trial (BEST)
|
Phase 4 | |
Completed |
NCT00210431 -
Post Marketing Surveillance Study of Dysport
|
||
Completed |
NCT00076687 -
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
|
Phase 2 |